STOCK TITAN

[SCHEDULE 13G] Alignment Healthcare, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Qatar Investment Authority and its subsidiary Q Healthcare Holding LLC filed a Schedule 13G reporting ownership of 13,246,096 shares of Alignment Healthcare, Inc. common stock, representing 6.69% of the outstanding shares. The filing states each reporting person has sole voting and sole dispositive power over those shares and that the percent was calculated using 198,031,417 shares outstanding per Alignment Healthcares July 25, 2025 disclosure. The statement includes a joint filing agreement and a certification that the stake was not acquired to influence control of the issuer.

Qatar Investment Authority e la sua controllata Q Healthcare Holding LLC hanno depositato un Schedule 13G che segnala la proprietà di 13.246.096 azioni delle azioni ordinarie di Alignment Healthcare, Inc., pari al 6,69% delle azioni in circolazione. L'atto di deposito indica che ciascun soggetto dichiarante detiene potere di voto esclusivo e potere dispositivi esclusivo su tali azioni e che la percentuale è stata calcolata utilizzando 198.031.417 azioni in circolazione secondo la divulgazione di Alignment Healthcare del 25 luglio 2025. La dichiarazione include un accordo di deposito congiunto e una certificazione che la partecipazione non è stata acquisita per influenzare il controllo dell'emittente. The filing states a ciascun soggetto dichiarante detiene potere di voto esclusivo e potere dispositivi esclusivo su tali azioni e che la percentuale è stata calcolata usando 198.031.417 azioni in circolazione secondo la divulgazione del 25 luglio 2025 di Alignment Healthcare. La dichiarazione comprende un accordo di deposito congiunto e una certificazione che l'interesse non è stato acquisito per influenzare il controllo dell'emittente.

La Qatar Investment Authority y su filial Q Healthcare Holding LLC presentaron un Schedule 13G informando la propiedad de 13,246,096 acciones de las acciones ordinarias de Alignment Healthcare, Inc., que representan el 6,69% de las acciones en circulación. La presentación indica que cada persona que informa tiene poder de voto exclusivo y poder dispositivos exclusivo sobre esas acciones y que el porcentaje se calculó usando 198,031,417 acciones en circulación según la divulgación de Alignment Healthcare del 25 de julio de 2025. La declaración incluye un acuerdo de presentación conjunta y una certificación de que la participación no se adquirió para influir en el control del emisor.

카타르 투자청(QIA)와 그 자회사 Q Healthcare Holding LLC는 Alignment Healthcare, Inc. 보통주의 13,246,096주에 대한 소유를 보고하는 Schedule 13G를 제출했으며, 이는 발행주식 총수의 6.69%를 차지합니다. 제출서에는 각 보고하는 사람이 해당 주식에 대해 단일 의결권과 단일 처분 권한을 보유하고 있으며 해당 백분율은 Alignment Healthcare의 2025년 7월 25일 공시 기준 유통주식 198,031,417주를 사용해 계산되었다고 명시되어 있습니다. 성명서는 공동 제출 합의서와 지분이 발행인의 지배력을 좌우하기 위해 취득된 것이 아님이라는 인증서를 포함합니다.

L'Autorité d'investissement du Qatar et sa filiale Q Healthcare Holding LLC ont déposé un Schedule 13G déclarant la propriété de 13 246 096 actions ordinaires d'Alignment Healthcare, Inc., représentant 6,69% des actions en circulation. Le dépôt indique que chaque personne déclarant détient seul le droit de vote et le pouvoir discrétionnaire sur ces actions et que le pourcentage a été calculé en utilisant 198 031 417 actions en circulation selon la divulgation du 25 juillet 2025 d'Alignment Healthcare. La déclaration inclut un accord de dépôt conjoint et une certification que la participation n'a pas été acquis pour influencer le contrôle de l'émetteur.

Die Qatar Investment Authority und ihre Tochtergesellschaft Q Healthcare Holding LLC haben eine Schedule 13G eingereicht, in der Eigentum an 13.246.096 Aktien von Alignment Healthcare, Inc. Stammaktien gemeldet wird, was 6,69% der ausstehenden Aktien entspricht. Die Einreichung besagt, dass jede meldende Person allein über Stimm- und dispositive Macht über diese Aktien verfügt und dass der Prozentsatz unter Verwendung von 198.031.417 ausstehenden Aktien gemäß der Alignment Healthcare-Mitteilung vom 25. Juli 2025 berechnet wurde. Die Erklärung enthält eine Vereinbarung über gemeinsames Einreichen und eine Bestätigung, dass der Anteil nicht erworben wurde, um die Kontrolle des Emitenten zu beeinflussen.

قامت هيئة قطر للاستثمار وشركتها القابضة Q Healthcare Holding LLC بتقديم Schedule 13G للإبلاغ عن امتلاك 13,246,096 سهماً من أسهم Alignment Healthcare, Inc. العادية، وهو ما يمثل 6.69% من الأسهم القائمة. وتنص الإفادة على أن كل جهة مُبلِّغة تمتلك سلطة التصويت الحصرية وسلطة التصرف الحصرية على تلك الأسهم، وأن النسبة تم حسابها باستخدام 198,031,417 سهماً قائماً وفقاً للإفصاح الصادر عن Alignment Healthcare بتاريخ 25 يوليو 2025. وتشمل البيان اتفاق تقديم مشترك وشهادة بأن الملكية لم تُكتسب بغرض التأثير في سيطرة المُصدر.

卡塔尔投资局及其子公司 Q Healthcare Holding LLC 提交了 Schedule 13G,报告其持有 Alignment Healthcare, Inc. 的普通股共 13,246,096 股,约占已发行股本的 6.69%。申报中称每位申报主体对这些股份拥有单独投票权和单独处置权,且该百分比是以 Alignment Healthcare 截至 2025 年 7 月 25 日披露的 198,031,417 股已发行股份为基础计算的。该声明还包含联合申报协议及一项证明,表明此次持股并非为了影响发行人控制权而取得。

Positive
  • Reported beneficial ownership of 13,246,096 shares (6.69%) which is material and transparent
  • Sole voting and sole dispositive power clearly disclosed for the reported shares
  • Filed as Schedule 13G with a certification indicating passive intent and regulatory compliance
  • Includes a joint filing agreement demonstrating coordination in disclosure between QIA and its subsidiary
Negative
  • None.

Insights

TL;DR: A sovereign investor disclosed a significant passive stake (6.69%) in ALHC with sole voting/dispositive power.

This Schedule 13G shows QIA and its subsidiary directly hold 13,246,096 shares, equal to 6.69% of Alignment Healthcare on the stated share base. The filing is presented under the passive investor regime and includes a certification that the holdings are not intended to change or influence control. For investors, a >5% disclosure by a large sovereign fund signals meaningful ownership concentration but the filing explicitly frames the position as non-control and passive.

TL;DR: Reporting indicates clear sole voting/dispositive authority but disclaims intent to influence control.

The document records sole voting and dispositive power for both QIA and Q Healthcare over the same block of shares and includes a joint filing agreement. The explicit disclaimer and Schedule 13G submission suggest a passive investment posture rather than an activist or control-seeking approach. Governance implications rest on whether future filings or board engagement follow; this filing alone does not allege coordination to change control.

Qatar Investment Authority e la sua controllata Q Healthcare Holding LLC hanno depositato un Schedule 13G che segnala la proprietà di 13.246.096 azioni delle azioni ordinarie di Alignment Healthcare, Inc., pari al 6,69% delle azioni in circolazione. L'atto di deposito indica che ciascun soggetto dichiarante detiene potere di voto esclusivo e potere dispositivi esclusivo su tali azioni e che la percentuale è stata calcolata utilizzando 198.031.417 azioni in circolazione secondo la divulgazione di Alignment Healthcare del 25 luglio 2025. La dichiarazione include un accordo di deposito congiunto e una certificazione che la partecipazione non è stata acquisita per influenzare il controllo dell'emittente. The filing states a ciascun soggetto dichiarante detiene potere di voto esclusivo e potere dispositivi esclusivo su tali azioni e che la percentuale è stata calcolata usando 198.031.417 azioni in circolazione secondo la divulgazione del 25 luglio 2025 di Alignment Healthcare. La dichiarazione comprende un accordo di deposito congiunto e una certificazione che l'interesse non è stato acquisito per influenzare il controllo dell'emittente.

La Qatar Investment Authority y su filial Q Healthcare Holding LLC presentaron un Schedule 13G informando la propiedad de 13,246,096 acciones de las acciones ordinarias de Alignment Healthcare, Inc., que representan el 6,69% de las acciones en circulación. La presentación indica que cada persona que informa tiene poder de voto exclusivo y poder dispositivos exclusivo sobre esas acciones y que el porcentaje se calculó usando 198,031,417 acciones en circulación según la divulgación de Alignment Healthcare del 25 de julio de 2025. La declaración incluye un acuerdo de presentación conjunta y una certificación de que la participación no se adquirió para influir en el control del emisor.

카타르 투자청(QIA)와 그 자회사 Q Healthcare Holding LLC는 Alignment Healthcare, Inc. 보통주의 13,246,096주에 대한 소유를 보고하는 Schedule 13G를 제출했으며, 이는 발행주식 총수의 6.69%를 차지합니다. 제출서에는 각 보고하는 사람이 해당 주식에 대해 단일 의결권과 단일 처분 권한을 보유하고 있으며 해당 백분율은 Alignment Healthcare의 2025년 7월 25일 공시 기준 유통주식 198,031,417주를 사용해 계산되었다고 명시되어 있습니다. 성명서는 공동 제출 합의서와 지분이 발행인의 지배력을 좌우하기 위해 취득된 것이 아님이라는 인증서를 포함합니다.

L'Autorité d'investissement du Qatar et sa filiale Q Healthcare Holding LLC ont déposé un Schedule 13G déclarant la propriété de 13 246 096 actions ordinaires d'Alignment Healthcare, Inc., représentant 6,69% des actions en circulation. Le dépôt indique que chaque personne déclarant détient seul le droit de vote et le pouvoir discrétionnaire sur ces actions et que le pourcentage a été calculé en utilisant 198 031 417 actions en circulation selon la divulgation du 25 juillet 2025 d'Alignment Healthcare. La déclaration inclut un accord de dépôt conjoint et une certification que la participation n'a pas été acquis pour influencer le contrôle de l'émetteur.

Die Qatar Investment Authority und ihre Tochtergesellschaft Q Healthcare Holding LLC haben eine Schedule 13G eingereicht, in der Eigentum an 13.246.096 Aktien von Alignment Healthcare, Inc. Stammaktien gemeldet wird, was 6,69% der ausstehenden Aktien entspricht. Die Einreichung besagt, dass jede meldende Person allein über Stimm- und dispositive Macht über diese Aktien verfügt und dass der Prozentsatz unter Verwendung von 198.031.417 ausstehenden Aktien gemäß der Alignment Healthcare-Mitteilung vom 25. Juli 2025 berechnet wurde. Die Erklärung enthält eine Vereinbarung über gemeinsames Einreichen und eine Bestätigung, dass der Anteil nicht erworben wurde, um die Kontrolle des Emitenten zu beeinflussen.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G




Comment for Type of Reporting Person: (1) Calculated based on 198,031,417 shares of common stock, $0.001 par value per share, outstanding as of July 25, 2025, as reported by Alignment Healthcare, Inc. in its Form 10-Q filed with the Securities and Exchange Commission on July 30, 2025.


SCHEDULE 13G





SCHEDULE 13G



Qatar Investment Authority
Signature:/s/ Mohammed Fahad Al Khulaifi
Name/Title:Mohammed Fahad Al Khulaifi, Head of Compliance
Date:09/24/2025
Q Healthcare Holding LLC
Signature:/s/ Mohammed Fahad Al Khulaifi
Name/Title:Mohammed Fahad Al Khulaifi, Head of Compliance
Date:09/24/2025
Exhibit Information

Exhibit 1 Joint Filing Agreement, dated September 24, 2025

FAQ

What stake did Qatar Investment Authority report in Alignment Healthcare (ALHC)?

The filing reports beneficial ownership of 13,246,096 shares, equal to 6.69% of outstanding common stock.

Does Qatar Investment Authority claim voting or disposition control over the ALHC shares?

Yes. The filing states each reporting person has sole voting and sole dispositive power over the 13,246,096 shares.

Under which SEC form was the ownership disclosed for ALHC?

Ownership was disclosed on a Schedule 13G, which is used for passive investors.

What share count was used to calculate the 6.69% ownership percentage?

The percentage was calculated using 198,031,417 shares outstanding, as reported by the company in its July 25, 2025 disclosure.

When was the Schedule 13G for ALHC signed?

The signatures on the filing are dated September 24, 2025.
Alignment Healthcare, Inc.

NASDAQ:ALHC

ALHC Rankings

ALHC Latest News

ALHC Latest SEC Filings

ALHC Stock Data

3.43B
165.43M
3.91%
96.87%
6.09%
Healthcare Plans
Hospital & Medical Service Plans
Link
United States
ORANGE